ITGB4 and ovarian cancer: Furthermore, blockade of ITGB4 signaling by an ITGB4-blocking antibody renders ovarian cancer cells unresponsive to Shh-stimulated migration and invasion, suggesting that the ITGB4 modulates Hh signaling in ovarian cancer migration and invasion (Figure 3).